U.S. News’ 2016 Best Global Universities ranked UAB among the top 200 in the world and top 75 in the United States, making UAB the highest-ranked university in Alabama.
The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
Students from the UAB School of Medicine honored the 27 faculty and three clinical department winners of the 2015 Argus Awards at a ceremony on Friday, Oct. 2.
Nominations sought for the President's Diversity Award
Written by UAB Heersink School of Medicine News
The President's Diversity Award is an annual honor recognizing significant achievements of full-time faculty, staff and students toward developing a more culturally diverse, competent and inclusive university community.
Mentorship is key for increasing faculty satisfaction, engagement
Written by David Rogers, M.D., MHPE
My life and career have been substantially enriched by mentor-mentee relationships.
Beverly Jordan, M.D.
Written by Kendra Carter
Jordan is a 2006 graduate of the UAB School of Medicine and family medicine physician in Enterprise, Ala. After completing medical school, a residency in family medicine and a fellowship in sports medicine, Jordan set her sights on practicing in Enterprise for one reason: it’s the city nearest her hometown of Jack, Ala.
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
Julie Decker, program manager in the Department of Microbiology and Employee of the Month for February, will receive the highest non-academic employee award.
Community Engagement Institute links community leaders and academic researchers
Written by Christina Crowe
UAB’s Community Engagement Institute brings academic researchers and community leaders together to brainstorm ways to improve Birmingham, the region and the world.
UAB study finds possible frontline therapy for older patients with Hodgkin Lymphoma
Written by Beena Thannickal
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.